便秘治疗市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00005408
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Constipation Treatment Market Growth Analysis Report, 2031

Buy Now

便秘治疗市场规模预计将从 2022 年的 99.3 亿美元增至 2031 年的 176.9 亿美元。预计 2023-2031 年市场复合年增长率将达到 6.0%。对阿片类药物引起的便秘治疗的需求不断增长,这可能仍是便秘治疗市场的主要趋势。

便秘治疗市场分析

便秘在大量人群中的患病率不断上升是推动便秘治疗市场增长的主要因素之一。它是全球 16% 人口所经历的常见疾病之一,2023 年患病率为 33.5%。成年人便秘患病率不断上升与多种因素有关,包括饮食不当、缺乏体育锻炼、年龄增长导致排便减少等。便秘可导致心理疾病,影响生活质量。因此,便秘患病率的上升预计将推动便秘治疗市场的增长。

便秘治疗市场概况

便秘治疗市场主要受便秘患病率不断上升的推动,便秘患病率上升是由生活方式、药物和医疗条件等各种因素引起的,随后用于治疗便秘的产品开发、上市和批准也不断增加。此外,易患便秘的老年人口激增、饮食习惯的改变以及胃肠道疾病患病率的增加,预计这些因素将促进便秘治疗市场的增长。此外,各种组织和制造商的宣传活动不断增加,以及用于开发创新便秘治疗方案的研发活动激增,这些因素都有望推动市场增长。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

便秘治疗市场:

Constipation Treatment Market: Strategic Insights

Constipation Treatment Market
  • CAGR
    CAGR (2023 - 2031)
    6.0%
  • Market Size 2023
    US$ 9.93 billion
  • Market Size 2031
    US$ 17.69 billion

Key Players

  • AbbVies Inc
  • Takeda Pharmaceutical Company Limited
  • Bausch Health Companies Inc
  • Bayer AG
  • Mallinckrodt Plc
  • Sanofi
  • Albireo Pharma Inc
  • AstraZeneca
  • Ironwood Pharmaceuticals Inc
  • Salix Pharmaceuticals Inc

Regional Overview

Regional And Country Scope
  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

Segment 1治疗(泻药、氯离子通道激活剂、外周作用的 MU-阿片受体拮抗剂、GC-C 激动剂、5-HT4 受体激动剂)
    Segment2疾病(慢性特发性便秘、便秘性肠易激综合征、阿片类药物引起的便秘)
      Segment3分销渠道(医院药房、零售药房和网上药房)

        便秘治疗市场
        • Constipation Treatment Market
          复合年增长率(2023 - 2031)
          6.0%
        • 2023 年市场规模
          99.3 亿美元
        • 2031年市场规模
          176.9亿美元

        市场动态

        增长动力
        • 增加产品发布和批准
        • 便秘患病率不断上升
        未来的趋势
        • 对阿片类药物引起的便秘的治疗需求不断增加
        机会
        • 治疗便秘的药物研发

        关键人物;主力;重要一员

        • AbbVie 公司
        • 武田药品工业株式会社
        • 博士伦保健公司
        • 拜耳公司
        • 马林克罗德股份有限公司
        • 赛诺菲
        • Albireo Pharma 公司
        • 阿斯利康
        • Ironwood 制药公司
        • Salix Pharmaceuticals, Inc.

        区域概况

        Constipation Treatment Market
        • 北美
        • 欧洲
        • 亚太
        • 南美洲和中美洲
        • 中东和非洲

        市场细分

        Constipation Treatment Market治疗
        • 泻药
        • 氯离子通道激活剂
        • 外周作用的 MU 阿片受体拮抗剂
        • GC-C激动剂
        • 5-HT4 受体激动剂
        Constipation Treatment Market疾病
        • 慢性特发性便秘
        • 伴有便秘的肠易激综合征
        • 阿片类药物引起的便秘
        Constipation Treatment Market分销渠道
        • 医院药房
        • 零售药店
        • 网上药店
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

        便秘治疗市场驱动因素和机遇

        增加产品上市和审批以利于市场

        预测期内,FDA 批准和药物开发活动的增加可能会加速市场的增长。大多数老牌和新公司都在生产便秘药物,这将导致市场上药物供应充足。反过来,这有望促进这些药物的消费,从而推动便秘治疗市场的增长。例如,2021 年,美国食品药品监督管理局 (FDA) 批准了第一种仿制药利那洛肽 145 mcg 胶囊,以及迈兰制药的 290 mcg 胶囊,用于治疗便秘型肠易激综合征 (IBS-C) 和慢性特发性便秘。因此,预计产品发布和批准数量的增加将推动预测期内便秘治疗市场的增长。

        治疗便秘的药物开发——市场增长的机会

        强烈推荐使用泻药作为急性和轻度便秘的常规治疗方法。制药行业的发展已获得药物批准,例如鲁比前列酮、利那洛肽和普卡必利。然而,在对当前疗法没有反应的患者中,治疗便秘的基本需求尚未得到满足。5-HT4 受体调节剂 velusetrag、那罗那必利、鸟苷酸环化酶 C 激动剂普卡那肽和回肠胆汁酸转运体抑制剂 elobixibat 的最新发展和产品发布已被公认为有前途的药物。然而,正在进行各种研究来分析可以显著缓解便秘的药物的有效性。例如,2022 年 4 月,Ardelyx, Inc. 推出了 IBSRELA,这是第一种也是唯一一种用于治疗成人便秘型肠易激综合征 (IBS-C) 的 NHE3 抑制剂。此外,2022 年 8 月,FDA 批准使用 Vibrant Gastro 生产的首创疗法 Vibrant 治疗慢性便秘。因此,此类创新产品的推出预计将提供丰厚的增长机会。

        便秘治疗市场报告细分分析

        有助于得出便秘治疗市场分析的关键部分是治疗、疾病、分销渠道。

        • 根据治疗,便秘治疗市场细分为泻药、氯离子通道激活剂、外周作用的 MU-阿片受体拮抗剂、GC-C 激动剂和 5-HT4 受体激动剂。泻药部分在 2023 年占据了更大的市场份额。
        • 根据疾病,市场分为慢性特发性便秘、伴有便秘的肠易激综合征和阿片类药物引起的便秘。慢性特发性便秘在 2023 年占据了最大的市场份额。
        • 就分销渠道而言,市场分为医院药房、零售药房和在线药房。零售药房在 2023 年占据了市场主导地位。

        便秘治疗市场份额按地区分析

        便秘治疗市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

        由于便秘在所有人群中的患病率不断上升,北美在便秘治疗市场中占据主导地位。北美国家老年人口的大幅增加预计将为其增长做出巨大贡献。同样,参与开发治疗便秘药物的市场参与者可能会在预测期内促进市场增长。而在墨西哥,制药行业的发展和市场参与者为提高人们对便秘及其治疗的认识而做出的贡献预计将为市场的增长提供重要的增长机会。预计亚太地区将在未来几年以最高的复合年增长率增长。

        便秘治疗市场报告范围

        报告属性细节
        2023 年的市场规模99.3亿美元
        2031 年市场规模176.9亿美元
        全球复合年增长率(2023 - 2031)6.0%
        历史数据2021 - 2023
        预测期2024 - 2031
        涵盖的领域通过治疗
        • 泻药
        • 氯离子通道激活剂
        • 外周作用的 MU 阿片受体拮抗剂
        • GC-C激动剂
        • 5-HT4 受体激动剂
        按疾病分类
        • 慢性特发性便秘
        • 伴有便秘的肠易激综合征
        • 阿片类药物引起的便秘
        按分销渠道
        • 医院药房
        • 零售药店
        • 网上药店
        覆盖地区和国家北美
        • 我们
        • 加拿大
        • 墨西哥
        欧洲
        • 英国
        • 德国
        • 法国
        • 俄罗斯
        • 意大利
        • 欧洲其他地区
        亚太
        • 中国
        • 印度
        • 日本
        • 澳大利亚
        • 亚太其他地区
        南美洲和中美洲
        • 巴西
        • 阿根廷
        • 南美洲和中美洲其他地区
        中东和非洲
        • 南非
        • 沙特阿拉伯
        • 阿联酋
        • 中东和非洲其他地区
        市场领导者和主要公司简介
        • AbbVie 公司
        • 武田药品工业株式会社
        • 博士伦保健公司
        • 拜耳公司
        • 马林克罗德股份有限公司
        • 赛诺菲
        • Albireo Pharma 公司
        • 阿斯利康
        • Ironwood 制药公司
        • Salix Pharmaceuticals, Inc.
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

        便秘治疗市场新闻和最新发展

        便秘治疗市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是便秘市场的发展和策略列表:

        • 全球制药巨头 Lupin Limited 的消费者保健业务 Lupin Life 推出了 Softovac Liquifibre,这是一款 100% 阿育吠陀液体泻药。借助这款创新产品,该公司进入了印度液体泻药市场,该产品是液体形式的 Isabgol 纤维和 Sonamukhi、Harad、Mulethi、Saunf、Amaltas 和 Gulab Dal 等天然活性成分的配方。(来源:Lupin,公司网站,2023 年)
        • Ironwood Pharmaceuticals, Inc. 是一家专注于胃肠道的医疗保健公司,该公司已获得美国食品药品管理局 (FDA) 批准 LINZESS(利那洛肽)用于治疗 6-17 岁功能性便秘儿科患者,每日一次。 LINZESS 是首个也是唯一一个获得 FDA 批准的治疗此类患者功能性便秘的处方药。(来源:Ironwood,公司网站,2023 年)
        • EA Pharma 的母公司卫材株式会社和持田制药株式会社在日本推出了用于治疗慢性便秘的 MOVICOL HD。MOVICOL HD 含有相同的活性成分,但每袋的含量是 MOVICOL LD 的两倍。它通过其主要成分聚乙二醇 (macrogol 4000) 的渗透压增加肠道中的水分保留,从而增加粪便水分,软化粪便,增加粪便量,并在生理上激活结肠的蠕动运动以促进排便。(来源:卫材株式会社,公司网站,2022 年)
        • Ardelyx, Inc. 推出了 IBSRELA,这是首个也是唯一一个用于治疗成人便秘型肠易激综合征 (IBS-C) 的 NHE3 抑制剂。该药物可治疗腹痛、腹胀和不适,以及与这种使人衰弱的疾病相关的便秘。(来源:Ardelyx, Inc.,通讯,2022 年)

        便秘治疗市场报告覆盖范围和交付成果

        “便秘治疗市场规模和预测(2021-2031 年)”报告对以下领域进行了详细的市场分析:

        • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
        • 市场动态,如驱动因素、限制因素和关键机遇
        • 未来主要趋势
        • 详细的 PEST/波特五力分析和 SWOT 分析
        • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
        • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
        • 详细的公司简介

        Constipation Treatment Market Report Scope

        Report Attribute Details
        Market size in US$ 9.93 billion
        Market Size by US$ 17.69 billion
        Global CAGR 6.0%
        Historical Data 2021 - 2023
        Forecast period 2024 - 2031
        Segments Covered By 治疗(泻药、氯离子通道激活剂、外周作用的 MU-阿片受体拮抗剂、GC-C 激动剂、5-HT4 受体激动剂)
        By 疾病(慢性特发性便秘、便秘性肠易激综合征、阿片类药物引起的便秘)
        By 分销渠道(医院药房、零售药房和网上药房)
        Regions and Countries Covered 北美(美国、加拿大、墨西哥)
        • 北美(美国、加拿大、墨西哥)
        欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        Market leaders and key company profiles
      • AbbVies Inc
      • Takeda Pharmaceutical Company Limited
      • Bausch Health Companies Inc
      • Bayer AG
      • Mallinckrodt Plc
      • Sanofi
      • Albireo Pharma Inc
      • AstraZeneca
      • Ironwood Pharmaceuticals Inc
      • Salix Pharmaceuticals Inc
      • Report Coverage
        Report Coverage

        Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

        Segment Covered
        Segment Covered

        This text is related
        to segments covered.

        Regional Scope
        Regional Scope

        North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

        Country Scope
        Country Scope

        This text is related
        to country scope.

        The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

        1. Data Collection and Secondary Research:

        As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

        Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

        1. Primary Research:

        The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

        For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

        A typical research interview fulfils the following functions:

        • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
        • Validates and strengthens in-house secondary research findings
        • Develops the analysis team’s expertise and market understanding

        Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

        • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
        • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

        Below is the breakup of our primary respondents by company, designation, and region:

        Research Methodology

        Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

        1. Data Analysis:

        Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

        • Macro-Economic Factor Analysis:

        We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

        • Country Level Data:

        Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

        • Company Profile:

        The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

        • Developing Base Number:

        Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

        1. Data Triangulation and Final Review:

        The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

        We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

        We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

        Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

        Trends and growth analysis reports related to Pharmaceuticals : READ MORE..